Browse drugs

…n and expenditure in statin was contributed by atorvastatin and rosuvastatin. After the NVBP policy, the utilisation of atorvastatin and ros…

…ty (53% of patients who had a discussion) gave consent to begin statins. Only 28 (56% of consenting patients) were prescribed a statin.…

…vastatin/rosuvastatin) statins; (2A) P-glycoprotein inhibitors (simvastatin/atorvastatin) versus non-inhibitors (pravastatin) in patients p…

…rdial infarction (STEMI) and is associated with poor prognosis. Statins exert pleiotropic effects beyond lipid-lowering, including anti…

…n 10.5 years; 71.4% male), of whom 80.2% were on high-intensity statins. Comorbidities included prior CAD (31.9%), hypertension (64.8%)…

…mm, 28.8 ± 5.41 vs 28.3 ± 4.98, p=0.85) was similar between the statin-pre-treated and statin-naïve group, despite the former achieving lower leve…

…tions. Anti-inflammatory and endothelial stabilizing actions of statins have resulted in attention for use in SAH. Statin use may cause…

…y referralB: Patient-facing educational leafletsC: Report-level statin recommendation (correct)D: Repeat CAC scanning at 12 monthsE: I…

…eated with geroprotector drugs including metformin, statins and fisetin, every 2 days for 7 days. Transcription factors (including MYC)…

…h individual and combination LLT, including statins, ezetimibe, bempedoic acid, and PCSK9 inhibitors. Admission lipid profile and pre-ACS LLT …

…Introduction Statins are cornerstone therapy in cardiovascular prevention, plaque re…

…selling should be strengthened to improve patient acceptance of statins. Statin tolerability was good with low discontinuation rates. L…